Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. Juli 2023 14:39 ET | Quelle: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research Appoints Two New Members, Calvin Harris Jr., CPA and Joel D. Rosen, Esq., to Board of Directors

CHICAGO, July 13, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of Calvin Harris Jr., CPA and Joel D. Rosen, Esq. to the FSR Board of...
22. Mai 2023 10:15 ET | Quelle: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research Releases White Paper and Hosts Congressional Briefing on Advancing Clinical Trial Equity for Black Patients with Sarcoidosis

CHICAGO, May 22, 2023 (GLOBE NEWSWIRE) -- Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to elevating research, raising awareness and providing support...
09. Mai 2023 10:38 ET | Quelle: AI Therapeutics, Inc.

AI Therapeutics Announces Poster Presentation at the 2023 American Thoracic Society International Conference

GUILFORD, Conn., May 09, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today Dr Antje Prasse...
30. März 2023 11:43 ET | Quelle: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research launches the Stand Up for Sarc National Campaign for April’s Awareness Month for the 175,000+ People in the U.S. Living with Sarcoidosis

CHICAGO, March 30, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is proud to launch the Stand Up for Sarc Campaign this April as part of National Sarcoidosis Awareness...
30. März 2023 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces First Major Review Article for Efzofitimod Published in the Journal Sarcoidosis, Vasculitis and Diffuse Lung Diseases

SAN DIEGO, March 30, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary...
28. Februar 2023 14:56 ET | Quelle: Foundation for Sarcoidosis Research

Foundation for Sarcoidosis Research (FSR) Inaugural Sarcoidosis Crystal Awards Gala to honor actor, Jeryl Prescott Gallien, Dr. George Mensah, Director of The Center for Translation Research and Implementation Science from the NIH, news anchor and podcaster, John Carlin, and world-renowned sarcoidosis researcher, Dr. Marjolein Drent

CHICAGO, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure and improving care for...
17. Mai 2022 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Presents Clinical Data for Efzofitimod (ATYR1923) at the American Thoracic Society 2022 International Conference

Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate dose-dependent improvements in key physiologic and quality of life measures in context of a steroid taper. ...
06. Januar 2022 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces FDA Orphan Drug Designation for ATYR1923 for Treatment of Sarcoidosis

SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on...
20. April 2021 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma and Foundation for Sarcoidosis Research Announce Town Hall Virtual Meeting on Steroids and Sarcoidosis

SAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...
08. April 2021 08:00 ET | Quelle: aTyr Pharma, Inc.

aTyr Pharma Announces Co-Founder of the Foundation for Sarcoidosis Research and Leading Sarcoidosis Advocate Andrea Wilson as Patient Advisor

SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological...

Vorherige Seite

Nächste Seite